Clinicians' use of breast cancer risk assessment tools according to their perceived importance of breast cancer risk factors: an international survey.
BOADICEA
Breast cancer risk assessment
Clinical practice
Factors
Survey
Tools
Journal
Journal of community genetics
ISSN: 1868-310X
Titre abrégé: J Community Genet
Pays: Germany
ID NLM: 101551501
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
12
10
2017
accepted:
20
02
2018
pubmed:
7
3
2018
medline:
7
3
2018
entrez:
7
3
2018
Statut:
ppublish
Résumé
The BOADICEA breast cancer (BC) risk assessment model and its associated Web Application v3 (BWA) tool are being extended to incorporate additional genetic and non-genetic BC risk factors. From an online survey through the BOADICEA website and UK, Dutch, French and Swedish national genetic societies, we explored the relationships between the usage frequencies of the BWA and six other common BC risk assessment tools and respondents' perceived importance of BC risk factors. Respondents (N = 443) varied in age, country and clinical seniority but comprised mainly genetics health professionals (82%) and BWA users (93%). Oncology professionals perceived reproductive, hormonal (exogenous) and lifestyle BC risk factors as more important in BC risk assessment compared to genetics professionals (p values < 0.05 to 0.0001). BWA was used more frequently by respondents who gave high weight to breast tumour pathology and low weight to personal BC history as BC risk factors. BWA use was positively related to the weight given to hormonal BC risk factors. The importance attributed to lifestyle and BMI BC risk factors was not associated with the use of BWA or any of the other tools. Next version of the BWA encompassing additional BC risk factors will facilitate more comprehensive BC risk assessment in genetics and oncology practice.
Identifiants
pubmed: 29508368
doi: 10.1007/s12687-018-0362-8
pii: 10.1007/s12687-018-0362-8
pmc: PMC6325038
doi:
Types de publication
Journal Article
Langues
eng
Pagination
61-71Subventions
Organisme : European Union Horizon 2020 research and innovation programme
ID : 634935
Organisme : Cancer Research UK
ID : C12292/A20891
Pays : United Kingdom
Organisme : INCa/DGOS
ID : 4654
Commentaires et corrections
Type : ErratumIn
Références
J Clin Oncol. 2002 Mar 15;20(6):1480-90
pubmed: 11896095
Stat Med. 2004 Apr 15;23(7):1111-30
pubmed: 15057881
J Med Genet. 2004 Jun;41(6):474-80
pubmed: 15173236
Br J Cancer. 2004 Oct 18;91(8):1580-90
pubmed: 15381934
J Med Genet. 2005 Jul;42(7):e39
pubmed: 15994864
Breast Cancer Res. 2007;9(5):213
pubmed: 17888188
Ann Intern Med. 2007 Oct 2;147(7):441-50
pubmed: 17909205
J Med Genet. 2008 Jul;45(7):425-31
pubmed: 18413374
Cochrane Database Syst Rev. 2009 Jul 08;(3):MR000008
pubmed: 19588449
Am J Hum Genet. 1991 Feb;48(2):232-42
pubmed: 1990835
J Natl Cancer Inst. 2010 May 19;102(10):680-91
pubmed: 20427433
Breast Cancer Res Treat. 2012 Apr;132(2):365-77
pubmed: 22037780
BMC Med Inform Decis Mak. 2012 Apr 10;12:30
pubmed: 22490389
Breast Cancer Res. 2012 Nov 05;14(6):R144
pubmed: 23127309
Fam Cancer. 2014 Mar;13(1):35-44
pubmed: 23934600
Br J Cancer. 2013 Sep 3;109(5):1296-301
pubmed: 23942072
Br J Cancer. 2014 Jan 21;110(2):535-45
pubmed: 24346285
Science. 2014 Mar 28;343(6178):1466-70
pubmed: 24675953
BMC Med Res Methodol. 2015 Jan 06;15:3
pubmed: 25563390
Cancer Epidemiol Biomarkers Prev. 2015 Apr;24(4):698-707
pubmed: 25613119
BMC Cancer. 2015 Apr 09;15:243
pubmed: 25886583
J Natl Cancer Inst. 1989 Dec 20;81(24):1879-86
pubmed: 2593165
Cancer Inform. 2015 May 10;14(Suppl 2):147-57
pubmed: 25983549
Am Soc Clin Oncol Educ Book. 2015;:e66-73
pubmed: 25993238
Breast Cancer Res Treat. 2015 Jul;152(1):193-197
pubmed: 26012643
N Engl J Med. 2015 Jun 4;372(23):2243-57
pubmed: 26014596
Fam Cancer. 2016 Jan;15(1):1-17
pubmed: 26334522
Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1495-506
pubmed: 26359465
Breast Cancer Res. 2015 Dec 01;17(1):147
pubmed: 26627479
Am Soc Clin Oncol Educ Book. 2016;35:44-56
pubmed: 27249685
Genet Med. 2016 Dec;18(12):1190-1198
pubmed: 27464310
J Clin Oncol. 2017 Mar;35(7):743-750
pubmed: 28029312
Breast Cancer Res. 2017 Mar 24;19(1):34
pubmed: 28340626
Breast Cancer Res Treat. 2017 Jul;164(2):263-284
pubmed: 28444533
Fam Cancer. 2018 Jan;17(1):31-41
pubmed: 28623477
JAMA. 1997 Oct 15;278(15):1242-50
pubmed: 9333265
Am J Hum Genet. 1998 Jan;62(1):145-58
pubmed: 9443863